Twist Bioscience (TWST) News Today $41.11 -0.21 (-0.51%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Cautious Outlook: Unfavorable Risk/Reward Profile for Twist Bioscience Amid Market ConcernsNovember 20 at 11:36 AM | markets.businessinsider.comFY2026 Earnings Estimate for TWST Issued By William BlairTwist Bioscience Co. (NASDAQ:TWST - Free Report) - Stock analysts at William Blair issued their FY2026 earnings per share (EPS) estimates for shares of Twist Bioscience in a report released on Monday, November 18th. William Blair analyst M. Larew expects that the company will post earnings per shNovember 20 at 7:18 AM | marketbeat.comTwist Bioscience Reports Record Revenue in 2024November 20 at 6:35 AM | markets.businessinsider.comVictory Capital Management Inc. Raises Stock Position in Twist Bioscience Co. (NASDAQ:TWST)Victory Capital Management Inc. increased its stake in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 7.7% in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 331,809 shares of the company's stock after acquiring an additionalNovember 20 at 3:29 AM | marketbeat.comBarclays Cuts Twist Bioscience (NASDAQ:TWST) Price Target to $52.00Barclays decreased their target price on Twist Bioscience from $55.00 to $52.00 and set an "overweight" rating on the stock in a research note on Tuesday.November 19 at 11:17 AM | marketbeat.comScotiabank Issues Positive Forecast for Twist Bioscience (NASDAQ:TWST) Stock PriceScotiabank increased their target price on shares of Twist Bioscience from $50.00 to $54.00 and gave the company a "sector outperform" rating in a research report on Tuesday.November 19 at 10:38 AM | marketbeat.comRobert W. Baird Issues Positive Forecast for Twist Bioscience (NASDAQ:TWST) Stock PriceRobert W. Baird boosted their target price on Twist Bioscience from $46.00 to $48.00 and gave the company an "outperform" rating in a research note on Tuesday.November 19 at 8:34 AM | marketbeat.comTwist Bioscience: Strong Market Position and Promising Growth Potential Justify Buy RatingNovember 19 at 8:30 AM | markets.businessinsider.comTwist Bioscience price target lowered to $52 from $55 at BarclaysNovember 19 at 8:30 AM | markets.businessinsider.comTwist Bioscience Corporation (NASDAQ:TWST) Q4 2024 Earnings Call TranscriptNovember 19 at 8:30 AM | msn.comThrivent Financial for Lutherans Makes New $43.99 Million Investment in Twist Bioscience Co. (NASDAQ:TWST)Thrivent Financial for Lutherans acquired a new stake in Twist Bioscience Co. (NASDAQ:TWST - Free Report) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 973,713 shares of the company's stock, valued at approximately $43,992,000. Thrivent FinanNovember 19 at 5:02 AM | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) Receives Average Recommendation of "Moderate Buy" from BrokeragesTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) has received an average recommendation of "Moderate Buy" from the nine research firms that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recNovember 19 at 3:41 AM | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) Shares Purchased by Principal Financial Group Inc.Principal Financial Group Inc. boosted its stake in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 67.5% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 205,864 shares of the company's stock afterNovember 19 at 3:10 AM | marketbeat.comTwist Bioscience: A Post-Earnings AssessmentNovember 18 at 4:10 PM | seekingalpha.comTwist Bioscience's Q4 Earnings And Q1 Guidance Surpass Expectations, Stock JumpsNovember 18 at 12:17 PM | benzinga.comTwist Bioscience Corporation (TWST) Q4 2024 Earnings Call TranscriptNovember 18 at 12:06 PM | seekingalpha.comTwist Bioscience (NASDAQ:TWST) Shares Gap Up - Here's WhyTwist Bioscience (NASDAQ:TWST) Shares Gap Up - Here's WhyNovember 18 at 11:09 AM | marketbeat.comTwist Bioscience Announces Fiscal 2024 Fourth Quarter and Full Year Financial ResultsNovember 18 at 7:15 AM | businesswire.comTwist Bioscience Corp (TWST) Q4 2024 Earnings Report Preview: What To Look ForNovember 16, 2024 | finance.yahoo.comTwist Bioscience Q4 2024 Earnings PreviewNovember 15, 2024 | msn.comTwist Bioscience Co. (NASDAQ:TWST) SVP Paula Green Sells 1,347 SharesNovember 14, 2024 | insidertrades.comSumitomo Mitsui Trust Group Inc. Sells 301,765 Shares of Twist Bioscience Co. (NASDAQ:TWST)Sumitomo Mitsui Trust Group Inc. decreased its holdings in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 9.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,861,666 shares of the compaNovember 14, 2024 | marketbeat.comBaillie Gifford & Co. Cuts Stake in Twist Bioscience Co. (NASDAQ:TWST)Baillie Gifford & Co. lessened its holdings in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 15.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 834,339 shares of the company's stock after selling 149,963 sharNovember 13, 2024 | marketbeat.comTwist Bioscience (TWST) to Release Quarterly Earnings on MondayTwist Bioscience (NASDAQ:TWST) will be releasing earnings before the market opens on Monday, November 18, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=639685)November 11, 2024 | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) CAO Sells $64,580.80 in StockNovember 9, 2024 | insidertrades.comTwist Bioscience Co. (NASDAQ:TWST) COO Patrick John Finn Sells 6,239 SharesNovember 9, 2024 | insidertrades.comQRG Capital Management Inc. Reduces Position in Twist Bioscience Co. (NASDAQ:TWST)QRG Capital Management Inc. lowered its holdings in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 53.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 27,522 shares of the company's stock after selliNovember 9, 2024 | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) CAO Robert F. Werner Sells 1,448 SharesTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) CAO Robert F. Werner sold 1,448 shares of the company's stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $44.60, for a total transaction of $64,580.80. Following the transaction, the chief accounting officer now owns 45,620 shares in the company, valued at approximately $2,034,652. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.November 8, 2024 | marketbeat.comAdam Laponis Sells 4,160 Shares of Twist Bioscience Co. (NASDAQ:TWST) StockTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) CFO Adam Laponis sold 4,160 shares of the company's stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $44.60, for a total value of $185,536.00. Following the completion of the sale, the chief financial officer now directly owns 89,237 shares in the company, valued at approximately $3,979,970.20. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.November 8, 2024 | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) COO Sells $278,259.40 in StockTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) COO Patrick John Finn sold 6,239 shares of the company's stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $44.60, for a total value of $278,259.40. Following the sale, the chief operating officer now owns 231,401 shares in the company, valued at approximately $10,320,484.60. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.November 8, 2024 | marketbeat.comARK Investment Management LLC Decreases Holdings in Twist Bioscience Co. (NASDAQ:TWST)ARK Investment Management LLC lowered its holdings in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 12.6% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 5,358,093 shares of the company's stock after selling 771,282 shares duriNovember 8, 2024 | marketbeat.comTwist Bioscience's Earnings Preview: Partnerships And Valuation Make It A 'Buy'November 8, 2024 | seekingalpha.comDennis Cho Sells 659 Shares of Twist Bioscience Co. (NASDAQ:TWST) StockNovember 7, 2024 | insidertrades.comTwist Bioscience Launches FlexPrep™ Ultra-High Throughput Library Preparation Kit for Applications in Agrigenomics and Population GenomicsOctober 30, 2024 | businesswire.comTWST Twist Bioscience CorporationOctober 29, 2024 | seekingalpha.comTwist Bioscience Co. (NASDAQ:TWST) COO Patrick John Finn Sells 2,261 SharesOctober 26, 2024 | insidertrades.comTwist Bioscience Co. (NASDAQ:TWST) COO Sells $97,426.49 in StockTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) COO Patrick John Finn sold 2,261 shares of Twist Bioscience stock in a transaction that occurred on Wednesday, October 23rd. The shares were sold at an average price of $43.09, for a total transaction of $97,426.49. Following the transaction, the chief operating officer now directly owns 159,483 shares of the company's stock, valued at approximately $6,872,122.47. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.October 25, 2024 | marketbeat.comLeerink Partners Remains a Hold on Twist Bioscience (TWST)October 25, 2024 | markets.businessinsider.comTwist Bioscience Co. (NASDAQ:TWST) Given Consensus Recommendation of "Moderate Buy" by AnalystsTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the nine ratings firms that are presently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating and seveOctober 25, 2024 | marketbeat.comPositive Outlook and Strong Pricing Strategy Justify Buy Rating for Twist BioscienceOctober 17, 2024 | markets.businessinsider.comBarclays Sticks to Their Buy Rating for Twist Bioscience (TWST)October 17, 2024 | markets.businessinsider.comTwist Bioscience (NASDAQ:TWST) Price Target Raised to $48.00 at Leerink PartnersLeerink Partners lifted their price target on shares of Twist Bioscience from $45.00 to $48.00 and gave the company a "market perform" rating in a report on Thursday.October 17, 2024 | marketbeat.comTwist Bioscience (NASDAQ:TWST) Shares Down 2.4% - What's Next?Twist Bioscience (NASDAQ:TWST) Shares Down 2.4% - Here's What HappenedOctober 16, 2024 | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) CFO Sells $35,789.36 in StockOctober 12, 2024 | insidertrades.comAdam Laponis Sells 856 Shares of Twist Bioscience Co. (NASDAQ:TWST) StockTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) CFO Adam Laponis sold 856 shares of the stock in a transaction that occurred on Wednesday, October 9th. The stock was sold at an average price of $41.81, for a total value of $35,789.36. Following the completion of the transaction, the chief financial officer now directly owns 73,397 shares of the company's stock, valued at approximately $3,068,728.57. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link.October 11, 2024 | marketbeat.comSquarepoint Ops LLC Cuts Stock Holdings in Twist Bioscience Co. (NASDAQ:TWST)Squarepoint Ops LLC cut its position in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 93.4% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 10,491 shares of the company's stock after selling 147,925 shares durinOctober 10, 2024 | marketbeat.comAQR Capital Management LLC Has $3.03 Million Holdings in Twist Bioscience Co. (NASDAQ:TWST)AQR Capital Management LLC grew its holdings in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 83.9% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 61,428 shares of the company's stock after purchasing an additioOctober 8, 2024 | marketbeat.comTwist Bioscience (NASDAQ:TWST) Shares Gap Down on Insider SellingTwist Bioscience (NASDAQ:TWST) Shares Gap Down After Insider SellingOctober 7, 2024 | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) Insider Sells $134,123.84 in StockOctober 5, 2024 | insidertrades.comTwist Bioscience (NASDAQ:TWST) Stock Quotes, Forecast and News SummaryOctober 4, 2024 | benzinga.com Get Twist Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for TWST and its competitors with MarketBeat's FREE daily newsletter. Email Address [625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin TWST Media Mentions By Week TWST Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TWST News Sentiment▼0.360.45▲Average Medical News Sentiment TWST News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TWST Articles This Week▼305▲TWST Articles Average Week Get Twist Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for TWST and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Iovance Biotherapeutics News Novavax News Vir Biotechnology News Relay Therapeutics News Allogene Therapeutics News Kodiak Sciences News Fate Therapeutics News Halozyme Therapeutics News Qiagen News Revolution Medicines News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TWST) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Twist Bioscience Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Twist Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
